TrxR2 Antibodies

Santa Cruz Biotechnology features a diverse variety of TrxR2 monoclonal antibodies for research focused on understanding thioredoxin reductase 2. TrxR2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Thioredoxin reductase 2 is a crucial enzyme involved in maintaining cellular redox balance and protecting cells from oxidative stress. TrxR2 plays a significant role in regulating cellular functions, including apoptosis and signaling pathways, making it an important target for studies related to cancer, neurodegenerative diseases, and other conditions associated with oxidative damage. Understanding TrxR2 function can provide insights into therapeutic strategies aimed at modulating oxidative stress responses. Research into TrxR2 continues to reveal new aspects of cellular redox regulation and its impact on disease progression. Investigating TrxR2 expression patterns helps identify potential therapeutic targets in various pathological conditions. The role of TrxR2 in mitochondrial function makes it particularly relevant for studying metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TrxR2's role in health and disease.